Back to results
US 11,439,697 B2Granted
Nant cancer vaccine
AssigneesNantCell, Inc., Nant Holdings IP, LLC
InventorsPatrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Hans G. Klingemann, Laurent H. Boissel, Barry J. Simon
Life of this patent
Estimating the term…
Abstract
Cancer is treated using coordinated treatment regimens that uses various compounds and compositions that drive a tumor from the escape phase of cancer immunoediting to the elimination and equilibrium phase of cancer immunoediting.
Claims20
A method of treating cancer in a patient in need thereof, the method comprising:
- administering to the patient a sequence of therapeutics,
- wherein the sequence comprises a platinum chemotherapeutic, Nab-paclitaxel, haNK cells, an antibody for binding PD-L1, and IL-15 or IL-15N72D;
- wherein the therapeutics are administered in cycles;
- and
- wherein within the cycle the platinum chemotherapeutic and Nab-paclitaxel are administered before the haNK cells, PD-L1 antibody, and IL-15 or IL-15N72D.
2 more elements
Dependencies are inferred from the claim text.